Web-based screening and brief Intervention for substance using teens
| ISRCTN | ISRCTN95538913 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN95538913 |
| Protocol serial number | JUST/2010/DPIP/AG/0914-30-CE-0379823/00-48 |
| Sponsor | German Center for Addiction Research of Child and Adolescent (Germany) |
| Funders | European Commission (EU) ref: JUST/2010/DPIP/AG/0914-30-CE-0379823/00-48, German Centre for Addiction Research in Children and Adolescents, University Medical Centre Hamburg-Eppendorf (Germany), Laboratory of Social Psychiatry at Prague Psychiatric Center (Czech Republic), Stockholm Centre for Psychiatric Research and Education, Stockholm County Council Health Care Provision and Karolinska Institute (Sweden), Vereniging voor Alcohol en andere Drugproblemen vzw (VAD) (Belgium), Universität Lund, Clinical Alcohol Research, Skane University Hospital (Sweden) |
- Submission date
- 12/06/2012
- Registration date
- 16/07/2012
- Last edited
- 31/03/2017
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Mental and Behavioural Disorders
Plain English summary of protocol
Background and study aims
Adolescents aged 16 to 18 are at risk of problematic drinking and illegal drug use. While the short- and long-term effects are a major public health concern, current prevention programs targeting alcohol- and other drug-using adolescents are scarce. The aim of this study is to test the effectiveness of a web-based brief intervention aimed at reducing problematic alcohol use and abstaining from illegal drugs among adolescents aged 16 to 18 in Belgium, Germany, Czech Republic and Sweden.
Who can participate?
Adolescents aged 16 to 18 from Sweden, Czech Republic, Belgium and Germany who are tested for and found to be at risk of alcohol and drugs-related problems
What does the study involve?
Participants are randomly allocated to one of two groups. One group receives the web-based intervention, which takes about 10 to 15 minutes. The intervention provides feedback on participants’ alcohol and drug use, including the risks, and practical advice to encourage reduced drinking and abstinence from illegal drugs. The other group receives no intervention. Both groups’ use of alcohol and drugs is measured at the start of the study and at 3 months follow-up.
What are the possible benefits and risks of participating?
Not provided at time of registration
Where is the study run from?
University Hospital Hamburg-Eppendorf (Germany)
When is the study starting and how long is it expected to run for?
June 2012 to January 2013
Who is funding the study?
1. European Commission (EU)
2. University Hospital Hamburg-Eppendorf (Germany)
3. Laboratory of Social Psychiatry at Prague Psychiatric Center (Czech Republic)
4. Stockholm Centre for Psychiatric Research and Education, Stockholm County Council Health Care Provision and Karolinska Institute (Sweden)
5. Vereniging voor Alcohol en andere Drugproblemen vzw (VAD) (Belgium)
6. Universität Lund, Clinical Alcohol Research, Skane University Hospital (Sweden)
Who is the main contact?
Prof Rainer Thomasius
thomasius@uke.uni-hamburg.de
Contact information
Scientific
Deutsches Zentrum für Suchtfragen des Kindes und Jugendalters
University Hospital Hamburg-Eppendorf
Center for Psychosocial Medicine
Martinistrasse 52
Hamburg
20246
Germany
| thomasius@uke.uni-hamburg.de |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Two-arm randomized controlled trial study |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Web-based screening and brief Intervention for SubstancE using teens: a randomised controlled trial |
| Study acronym | WISEteens |
| Study objectives | Adolescents with risky substance use who participate in the WISEteens intervention show lower levels of substance consumption and higher levels of substance reduction and abstinence related cognitions as opposed to those who receive an assessment only. |
| Ethics approval(s) | 1. Hamburg, Chamber of Physicians,Germany, 10/04/2012 ref: PV4087 2. Ethics Committee of Prague Psychiatric Centre, Czech Republic, 18/04/2012, ref: 49/12 3. The Regional Ethical Review Board Karolinska Institutet, Sweden, ref: nr 2012/462-31/3 4. Committee for Medical Ethics, University of Antwerp, Belgium (Comité voor medische ethiek Universiteit Antwerpen), ref: B300201214283 |
| Health condition(s) or problem(s) studied | Prevention of continued risky substance consumption among young persons |
| Intervention | The overarching goal of the intervention is to encourage reduced alcohol consumption and abstinence of any illicit drugs. The intervention relies on a single session, is fully electronically delivered (automatic) yet interactive. It works with presenting tailored feedback to the participants responses in the earlier assessment (i.e., consumption levels) and provides choice options to react to this feedback. This interactivity simulates a face-to face dialogue, which aims for an empathic style, avoids argumentation, rolls with resistance and aims at creating a dissonance between actual and desired behavior and raising self-efficacy. In these goals, our intervention basically comprises of three components. First, participants will receive personalized feedback on their substance consumption patterns including the associated risks (related to health and other consequences) and comparisons to a normative reference group. Second, participants engage in interactive MI-based exercises that have been proven effective in prompting readiness to change by encouraging the participant to consider the costs and benefits of their current substance use and actual change. Finally, the intervention will include practical advice concerning alternative behavior in tempting situations, with a focus on peer resistance skills to raise self-efficacy beliefs and implementation intentions. All components will be described in more detail below. Time to complete the intervention is supposed to take 10 to 15 minutes approximately. The control group will get no intervention. Participants are invited to visit again and participate after the evaluation period of the intervention of 3 months. |
| Intervention type | Behavioural |
| Primary outcome measure(s) |
Frequency and quantity of use of alcohol and drugs other than alcohol over a 30 day period, as well as consumption per typical occasion |
| Key secondary outcome measure(s) |
1. Additional behavioral outcomes including peak drinking quantity |
| Completion date | 25/01/2013 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Child |
| Lower age limit | 16 Years |
| Upper age limit | 18 Years |
| Sex | All |
| Target sample size at registration | 800 |
| Key inclusion criteria | 1. Age between 16 and 18 years 2. A positive screen on the CRAFFT for risky substance use 3. Informed consent of the participants 4. Access to the internet |
| Key exclusion criteria | Does not meet inclusion criteria |
| Date of first enrolment | 25/06/2012 |
| Date of final enrolment | 25/01/2013 |
Locations
Countries of recruitment
- Belgium
- Czech Republic
- Germany
- Sweden
Study participating centre
20246
Germany
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 24/05/2016 | Yes | No | |
| Protocol article | protocol | 26/09/2012 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
31/03/2017: Plain English summary added.
26/05/2016: Publication reference added.
